NSE - Free Realtime Quote INR

Bajaj HealthCare Limited (BAJAJHCARE.NS)

Compare
398.00
+2.60
+(0.66%)
As of 11:14 AM GMT+5:30. Market Open.
Loading Chart for BAJAJHCARE.NS
DELL
  • Previous Close 395.40
  • Open 392.30
  • Bid 397.50 x --
  • Ask 398.45 x --
  • Day's Range 392.30 - 400.45
  • 52 Week Range 263.30 - 428.50
  • Volume 33,100
  • Avg. Volume 157,524
  • Market Cap (intraday) 12.57B
  • Beta (5Y Monthly) 0.58
  • PE Ratio (TTM) --
  • EPS (TTM) -3.72
  • Earnings Date Feb 7, 2025 - Feb 11, 2025
  • Forward Dividend & Yield 1.00 (0.26%)
  • Ex-Dividend Date Sep 23, 2024
  • 1y Target Est --

Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, venous disease, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides intermediates, such as guanine, 3-methyl xanthine, bromoethyl theophylline, calcium phosphoryl choline chloride, 4-hydrazinobenzoic acid, ticagrelor acetonide, 4,7-dichloroquinolone, 5-[N-ethyl-N-(2-hydroxyethyl)amino]-2-aminopentane, 2-amino -4-hydroxyacetophenone, 8- chloro theophylline, 8 bromo-3-methyl xanthine, 3-methyl-7-(2-butyn-1-yl)-8-bromo xanthine, (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile, 3 – amino – 1 – adamantanol, N – boc -sitagliptin, sitagliptin base, hesperidine, (2,7-dichlori-9H-fluorene), (2-Chloro-1-(2,7- dichlori-9H-fluoren-4-yl)ethanone), (2-(dibutylamino)-1-(2, 7- dichlori-9H-fluoren-4-yl)ethanol), (2-Nitro-4-thiocyanoaniline), 4- (propylthio) benzene -1,2-diamine, methyl [(E)amino(methylsulfanyl)methylidene] carbamate, and (2-phenoxy methane sulphonamide). In addition, the company offers formulations in the form of tablets, capsules, sachets, and vials, as well as impurities. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.

www.bajajhealth.com

1,049

Full Time Employees

March 31

Fiscal Year Ends

Recent News: BAJAJHCARE.NS

View More

Performance Overview: BAJAJHCARE.NS

Trailing total returns as of 11/29/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BAJAJHCARE.NS
6.13%
S&P BSE SENSEX
10.47%

1-Year Return

BAJAJHCARE.NS
6.06%
S&P BSE SENSEX
20.60%

3-Year Return

BAJAJHCARE.NS
10.45%
S&P BSE SENSEX
39.75%

5-Year Return

BAJAJHCARE.NS
5.18%
S&P BSE SENSEX
94.03%

Compare To: BAJAJHCARE.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BAJAJHCARE.NS

View More

Valuation Measures

Annual
As of 11/27/2024
  • Market Cap

    12.47B

  • Enterprise Value

    13.95B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.16

  • Price/Book (mrq)

    2.80

  • Enterprise Value/Revenue

    2.76

  • Enterprise Value/EBITDA

    27.79

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.98%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    4.76B

  • Net Income Avi to Common (ttm)

    -133.27M

  • Diluted EPS (ttm)

    -3.72

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    29.29M

  • Total Debt/Equity (mrq)

    119.57%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: BAJAJHCARE.NS

View More

Company Insights: BAJAJHCARE.NS

Research Reports: BAJAJHCARE.NS

View More

People Also Watch